StockWatch
·

Molbio Diagnostics Ltd

BSE: 544866

P/L Snapshot

Q1 FY27 · standalone

Revenue
400.75
Expenditure
324.82
Net Profit
56.63
OPM %
22.94%

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00112.21224.42336.63448.84Q1 FY27
Price Chart
Reports

Lumpy Government, Unproven Sequels—25% Growth On Track If Execution Holds

Government diagnostics · TB program · Rate contract delay

Result verdictFollow-upQ2 FY2711 Nov 20266 minPharma & Healthcare

H1 Miss on Rate Delays, FY27 25% Growth On Track

Government tenders · Truenant platform · Veterinary expansion

TranscriptDeep diveQ2 FY2711 Nov 20266 minPharma & Healthcare

Platform Scaling Meets Acquisition Headwinds—Too Early to Call the Trade-Off

point-of-care · Truenat · OptraScan

Result verdictFollow-upQ1 FY2712 Sept 20266 min
Latest

Corporate Events

Board MeetingMOLBIO
2026
5Nov

Board Meeting

To consider and approve the Unaudited financial results (Sta…

BSE Filing ↗
Board MeetingMOLBIO
2026
25Sep

Board Meeting

The Board of Directors considered and approved the re-appoin…

BSE Filing ↗
Board MeetingMOLBIO
2026
5Sep

Board Meeting

Approval of Un-audited Financial Results (Standalone & Conso…

BSE Filing ↗
Board MeetingMOLBIO
2026
27Aug

Board Meeting

The Board of Directors of the Company at their meeting held …

BSE Filing ↗